Table 4. Results of subgroup analyses for IH at the six-month and one-year follow-ups.
Subgroups | IH at 6-months follow-up | IH at 1-year follow-up | ||||||||
N studies | I2 (%) | OR [95% CI] | Psubgroup | Comments | N studies | I2 (%) | OR [95% CI] | Psubgroup | Comments | |
Study design | ||||||||||
RCT | 2 | 0 | 1.26 [0.55, 2.91] | 0.49 | No Sig. Diff. | 5 | 86 | 0.14 [0.03, 0.82] | 0.70 | No Sig. Diff. |
Observational | 1 | - | 0.43 [0.02, 8.34] | 3 | 0 | 0.21 [0.08, 0.59] | ||||
Mesh location | ||||||||||
Onlay | 1 | - | 0.43 [0.02, 8.34] | 0.49 | No Sig. Diff. | 3 | 50 | 0.13 [0.03, 0.52] | 0.28 | No Sig. Diff. |
Retrorectus | - | - | - | 2 | 0 | 0.07 [0.01, 0.38] | ||||
Preperitoneal | 2 | 0 | 1.26 [0.55, 2.91] | 2 | 59 | 0.60 [0.11, 3.14] | ||||
Intraperitoneal | - | - | - | 1 | - | 0.10 [0.02, 0.47] | ||||
Mean BMI | ||||||||||
<40 | 1 | - | 0.43 [0.02, 8.34] | 0.49 | No Sig. Diff. | 2 | 0 | 0.08 [0.02, 0.32] | 0.11 | No Sig. Diff. |
>40 | 2 | 0 | 1.26 [0.55, 2.91] | 5 | 60 | 0.33 [0.11, 1.00] | ||||
Study population | ||||||||||
Bariatric | 2 | 0 | 1.26 [0.55, 2.91] | 0.49 | No Sig. Diff. | 4 | 63 | 0.30 [0.07, 1.36] | 0.58 | No Sig. Diff. |
Neoplastic | - | - | - | 2 | 75 | 0.12 [0.02, 0.81] | ||||
Vascular | - | - | - | 1 | - | 0.04 [0.00, 0.72] | ||||
Mixed | 1 | - | 0.43 [0.02, 8.34] | 1 | - | 0.10 [0.02, 0.47] |